107 related articles for article (PubMed ID: 12165643)
1. Re: Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
Malayeri R
J Natl Cancer Inst; 2002 Aug; 94(15):1172; author reply 1172. PubMed ID: 12165643
[No Abstract] [Full Text] [Related]
2. Economic analysis of vinorelbine plus cisplatin versus paclitaxel plus carboplatin for advanced non-small-cell lung cancer.
Ramsey SD; Moinpour CM; Lovato LC; Crowley JJ; Grevstad P; Presant CA; Rivkin SE; Kelly K; Gandara DR
J Natl Cancer Inst; 2002 Feb; 94(4):291-7. PubMed ID: 11854391
[TBL] [Abstract][Full Text] [Related]
3. Docetaxel in combination with platinums (cisplatin or carboplatin) in advanced and metastatic non-small cell lung cancer.
Belani CP;
Semin Oncol; 2002 Jun; 29(3 Suppl 12):4-9. PubMed ID: 12170445
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.
Kelly K; Crowley J; Bunn PA; Presant CA; Grevstad PK; Moinpour CM; Ramsey SD; Wozniak AJ; Weiss GR; Moore DF; Israel VK; Livingston RB; Gandara DR
J Clin Oncol; 2001 Jul; 19(13):3210-8. PubMed ID: 11432888
[TBL] [Abstract][Full Text] [Related]
5. Cost-minimisation analysis comparing gemcitabine/cisplatin, paclitaxel/carboplatin and vinorelbine/cisplatin in the treatment of advanced non-small cell lung cancer in Italy.
Novello S; Kielhorn A; Stynes G; Selvaggi G; De Marinis F; Maestri A; Foggi P; Tilden D; Tonato M; Crinò L; Rinaldi M; Migliorino AM; Scagliotti GV;
Lung Cancer; 2005 Jun; 48(3):379-87. PubMed ID: 15893007
[TBL] [Abstract][Full Text] [Related]
6. Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non--small cell lung cancer: interim analysis.
Belani C;
Semin Oncol; 2001 Jun; 28(3 Suppl 9):10-4. PubMed ID: 11441409
[TBL] [Abstract][Full Text] [Related]
7. A retrospective comparison of adjuvant chemotherapeutic regimens for non-small cell lung cancer (NSCLC): paclitaxel plus carboplatin versus vinorelbine plus cisplatin.
Chang WJ; Sun JM; Lee JY; Ahn JS; Ahn MJ; Park K
Lung Cancer; 2014 Apr; 84(1):51-5. PubMed ID: 24521819
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic strategies in advanced non-small cell bronchial cancers: platin-based combinations].
Fournel P
Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S42-7. PubMed ID: 12538935
[No Abstract] [Full Text] [Related]
9. Concurrent radiochemotherapy with vinorelbine plus cisplatin or carboplatin in patients with locally advanced non-small-cell lung cancer (NSCLC) and an increased risk of treatment complications. Preliminary results.
Semrau S; Bier A; Thierbach U; Virchow C; Ketterer P; Fietkau R
Strahlenther Onkol; 2003 Dec; 179(12):823-31. PubMed ID: 14652671
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of unresectable non-small-cell lung cancer].
Ueoka H
Gan To Kagaku Ryoho; 2000 Mar; 27(3):356-61. PubMed ID: 10740628
[TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small-cell lung cancer.
Smith TJ; Hillner BE; Neighbors DM; McSorley PA; Le Chevalier T
J Clin Oncol; 1995 Sep; 13(9):2166-73. PubMed ID: 7666075
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant carboplatin-based chemotherapy in resected stage IIIA-N2 non-small cell lung cancer.
Ou W; Sun HB; Ye X; Zhang BB; Yang H; Fang Q; Li P; Wang SY
J Thorac Oncol; 2010 Jul; 5(7):1033-41. PubMed ID: 20502361
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of carboplatin, paclitaxel plus vinorelbine in non-small cell lung cancer patients.
Schmittel A; Siehl JM; Schulze M; Schulze K; Thiel E; Keilholz U
Anticancer Res; 2005; 25(2B):1333-6. PubMed ID: 15865087
[TBL] [Abstract][Full Text] [Related]
14. [Advanced non-small cell lung cancer responded to both vinorelbine and carboplatin over long-term outpatient treatment].
Chohnabayashi N; Uchiyama N; Nishimura N; Nasu H
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1395-8. PubMed ID: 15446564
[TBL] [Abstract][Full Text] [Related]
15. Docetaxel/platinum combination provides quality-of-life advantage over vinorelbine/cisplatin in advanced lung cancer.
Oncology (Williston Park); 2002 Aug; 16(8):1052. PubMed ID: 12201644
[No Abstract] [Full Text] [Related]
16. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
Hillner BE; Smith TJ
Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234
[TBL] [Abstract][Full Text] [Related]
17. [Lung carcinoma].
Sutani A; Kobayashi K
Gan To Kagaku Ryoho; 2006 May; 33(5):590-4. PubMed ID: 16685153
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin and vinorelbine in advanced non-small-cell lung cancer.
Pronzato P; Ghio E; Losardo PL; Landucci M; Vaira F; Vigani A
Cancer Chemother Pharmacol; 1996; 37(6):610-2. PubMed ID: 8612317
[TBL] [Abstract][Full Text] [Related]
19. Use of Adjuvant Cisplatin-Based Versus Carboplatin-Based Chemotherapy in Non-Small-Cell Lung Cancer: Findings From the Florida Initiative for Quality Cancer Care.
Tanvetyanon T; Lee JH; Fulp WJ; Schreiber F; Brown RH; Levine RM; Cartwright TH; Abesada-Terk G; Kim GP; Alemany C; Faig D; Sharp PV; Markham MJ; Malafa M; Jacobsen PB
J Oncol Pract; 2015 Jul; 11(4):332-7. PubMed ID: 25991639
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy for elderly patients with advanced non-small-cell lung cancer.
Bunn PA; Lilenbaum R
J Natl Cancer Inst; 2003 Mar; 95(5):341-3. PubMed ID: 12618492
[No Abstract] [Full Text] [Related]
[Next] [New Search]
